Key result
Discharge on warfarin after total knee arthroplasty was associated with a 0.21% readmission rate compared with 1.05% for patients discharged without further anticoagulation.
Why the study?
Does extended warfarin therapy reduce readmission for venous thromboembolism or bleeding in patients undergoing total knee arthroplasty?
Cohort (n=1,321)
Does extended warfarin therapy reduce readmission for venous thromboembolism or bleeding in patients undergoing total knee arthroplasty?
Extended warfarin prophylaxis after hospital discharge following total knee arthroplasty reduces venous thromboembolism-related readmissions compared to no anticoagulation.
Answers are grounded in this paper and cite their sources.
Warfarin at TKA discharge linked to fewer readmissions supports extended prophylaxis hypothesis; leaves open randomized confirmation before practice change.
Venous thromboembolism is the most common reason for readmission after total knee arthroplasty. Prospective contrast venography was conducted from 1984 to 2003 in 1321 patients undergoing total knee arthroplasty. Patients with deep venous thrombosis or pulmonary embolism were treated with warfarin; those with negative venograms received no further anticoagulation. From 1984 to 1992, patients not completing venography were discharged without warfarin; since 1993 patients without venography received warfarin for 6 weeks. Readmission for deep venous thrombosis, pulmonary embolism, or bleeding was tracked for 6 months. Venography was completed in 810 patients; 343 (42.3%) had deep venous thrombosis. Readmission for venous thromboembolism occurred in 0.6% of patients after total knee compared with 1.62% after total hip arthroplasty. Following total knee arthroplasty, patients discharged on warfarin (target INR 2.0) had a 0.21% readmission rate compared with 1.05% for patients with negative venograms discharged without further anticoagulation. One patient suffered a fatal pulmonary embolism after negative venography and no outpatient prophylaxis. Secondary prophylaxis with extended warfarin therapy reduced venous thromboembolism-related readmission. Surveillance venograms were a poor predictor of ultimate thromboembolism risk and need for extended anticoagulation therapy. We therefore recommend extended warfarin prophylaxis for all patients after hospital discharge following total knee arthroplasty.
No takes yet. Share an insight, caveat, or question.
Pellegrini et al. (2006) conducted a cohort in Total knee arthroplasty (n=1,321). Warfarin vs. No further anticoagulation was evaluated on Readmission for deep venous thrombosis, pulmonary embolism, or bleeding. Discharge on warfarin after total knee arthroplasty was associated with a 0.21% readmission rate compared with 1.05% for patients discharged without further anticoagulation.
Synapse has enriched 10 related papers. Consider them for comparative context: